Tuttle, R M <br/><br/>
Best Use of the Tyrosine Kinase Inhibitors in Progressive Differentiated Thyroid Cancer: Discussion.  [electronic resource] 

 -  Clinical advances in hematology & oncology : H&O  May 2016 
 - 12-3 p.  digital 
<br/><br/> Publication Type: Interview 
<br/><br/><label>ISSN: </label>1543-0790 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Disease Progression<br/>Drug Resistance, Neoplasm<br/>Genetic Testing<br/>Genetic Variation<br/>Humans<br/>Neoplasm Grading<br/>Neoplasm Metastasis<br/>Protein Kinase Inhibitors--pharmacology<br/>Protein-Tyrosine Kinases--antagonists & inhibitors<br/>Thyroid Neoplasms--diagnosis<br/>Treatment Outcome